Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.
about
Targeted treatment of chronic myeloid leukemia: role of imatinib.Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).Suboptimal response to or failure of imatinib treatment for chronic myeloid leukemia: what is the optimal strategy?Elevated expression of c-kit in small venous malformations of blue rubber bleb nevus syndromeTotal Leukocyte Counts and the Requirement of Dose Reduction due to Cytopenias as Prognostic Indicators Affecting Response to Imatinib in Chronic Myeloid Leukemia.
P2860
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@ast
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@en
type
label
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@ast
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@en
prefLabel
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@ast
Imatinib mesylate therapy of c ...... free survival in 150 patients.
@en
P2093
P1433
P1476
Imatinib mesylate therapy of c ...... -free survival in 150 patients
@en
P2093
Alberto Alvarez-Larrán
Eulogio Conde
Francisco Cervantes
Javier García-Conde
Javier López-Jiménez
Jesús Odriozola
Juan-Carlos Hernández-Boluda
Juan-Luis Steegmann
Lucía Villalón
Mireia Camós
P304
P577
2003-10-01T00:00:00Z